NCT04520529View on ClinicalTrials.gov

Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas

NANot yet recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

September 30, 2045

Study Completion Date

September 30, 2050

Conditions
Cutaneous Lymphoma
Interventions
OTHER

Biologic Samples

"* An additional punch from lesion skin as part of a skin biopsy performed as part of routine care.~* an additional blood sample will be collected for research during a blood test performed as part of the patient's routine care.~* In patients with clinical superficial lymphadenopathy or detected by imaging, and undergoing a superficial lymph node biopsy as part of the care, a core biopsy will be dedicated to research."

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04520529 - Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas | Biotech Hunter | Biotech Hunter